-

VectorBuilder Advances Free VectorBee Software to Help Researchers Work with Greater Control and Flexibility

Major VectorBee update reflects VectorBuilder’s continued investment in free, researcher-first tools for genetic engineering and vector design.

CHICAGO--(BUSINESS WIRE)--VectorBuilder, a global leader in gene delivery technologies, is launching a major update to VectorBee, its acclaimed 100% free DNA software created to help researchers view, edit, annotate, and analyze DNA and protein sequences with greater control and flexibility. Best of all, users transition seamlessly from design to order, avoiding the pain point of turning vector ideas into reality.

VectorBee, together with VectorBuilder, provides a solution from concept to clone — giving researchers time to focus on the research that matters, not the reagents that start the journey.

Share

The update reflects VectorBuilder’s ongoing investment in free tools that help researchers work through genetic engineering and vector design with less friction. VectorBee was created as a practical complement to VectorBuilder’s online vector design platform, giving researchers unlimited editing, annotation, and sequence analysis capabilities, previously only available through costly or clunky software, where utility stopped at design.

VectorBee was developed by a team of biologists and IT engineers led by Dr. Bruce Lahn, Chief Scientist of VectorBuilder. Dr. Lahn has decades of molecular biology experience and more than 100 publications, giving the software a strong scientific foundation rooted in how researchers work day-to-day. Dr. Lahn knew the importance of easy, efficient, and trustworthy vector designs.

“Vector design is one of the earliest and most important decisions in a gene delivery experiment,” said Lahn. “Researchers need tools that let them work through those decisions with flexibility and confidence. We built VectorBee to give the scientific community a free, intuitive environment for viewing, editing, annotating, and analyzing DNA and protein sequences without unnecessary complexity.”

VectorBuilder’s online Vector Design Studio remains ideal for the design needs of most researchers, with more than 80% of custom vectors designed directly through the online platform. VectorBee now features the Vector Design Wizard, giving users access to user-friendly design features as well as an additional level of control when they require more extensive customization, analysis, or sequence-level flexibility. Once users have finalized a vector design, whether a simple vector made in a few clicks or a highly complex design, VectorBee easily redirects them to VectorBuilder for cloning and downstream services. Where existing DNA software requires users to integrate cloning approaches into their design, then spend days, weeks, or longer getting the correct vector, VectorBee, together with VectorBuilder, provides a solution from concept to clone. Researchers are given time to focus on the research that matters, not the reagents that start the journey.

Since its launch in 2024, VectorBee has quickly gained traction among life sciences researchers worldwide. The software has attracted hundreds of thousands of users and has earned strong feedback from researchers who value its accessibility, user-friendliness, and flexibility.

The latest update presents VectorBee in its truest form: as a software not only for endless sequence viewing, editing, annotation, and analysis, but also for maximum, multi-modal integration with VectorBuilder’s backbones, components, and cloning capabilities. The value of the update extends beyond individual functions to support how researchers move between design decisions, sequence review, analysis, and downstream experimental steps.

“VectorBee is evolving alongside the needs of researchers,” said Lahn. “Some users need deeper editing, annotation, and sequence analysis capabilities than an online design interface can provide. The latest updates continue that work by giving researchers more flexibility while keeping the software highly intuitive and accessible.”

The software, especially the Vector Design Wizard, reflects VectorBuilder’s broader commitment to Good Vector Practice, which emphasizes designing vectors with feasibility, experimental goals, and downstream use in mind. VectorBuilder’s validated and optimized backbones and expansive database of components ensure users have a strong, reliable starting point. By giving researchers a free tool for more flexible and informed sequence design, VectorBee helps support better design decisions at the earliest stages of gene delivery work.

“Good vector design starts with understanding what you are building, why you are building it, and how design choices may affect later experimental steps. That is why VectorBee gives researchers a free, intuitive way to work through sequence design with more control. Our commitment is to keep VectorBee 100% free for all, forever, because researchers should have access to high-quality tools regardless of budget,” said Lahn.

VectorBee is available as a free download at www.vectorbee.com.

About VectorBuilder

VectorBuilder is a global leader in gene delivery technologies. As a trusted partner in thousands of labs and biotech/pharma companies around the world, VectorBuilder is a one-stop shop for the design, development, and optimization of gene delivery solutions from basic research to clinical applications. Its award-winning Vector Studio is a transformative innovation that allows researchers to easily design and order custom vectors online, freeing them from the tedious work of cloning and packaging vectors in the lab. The global company boasts high-throughput vector production capacity, vast vector and component inventories, one-on-one CRO solutions that include advanced AAV capsid engineering capabilities, and state-of-the-art GMP manufacturing facilities. With leading R&D and CDMO capabilities, the VectorBuilder team strives to provide the most effective gene-delivery solutions and develop innovative tools for life sciences research and genetic medicine.

Contacts

More News From VectorBuilder

VectorBuilder Partners With MaxCyte® to Advance Clinical-Grade Cell Engineering

ROCKVILLE, Md. & CHICAGO--(BUSINESS WIRE)--VectorBuilder, a global leader in gene delivery technologies and CDMO services, and MaxCyte, a leading, cell-engineering company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell therapeutics, today announced a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s proprietary MiniVec™ plasmid system and MaxCyte’s world-class clinical...

VectorBuilder to Invest $50 Million in Chicago Biomanufacturing and R&D Center

CHICAGO--(BUSINESS WIRE)--VectorBuilder, a global leader in gene delivery technologies, today announced plans to invest $50 million to establish a new Advanced Biomanufacturing and R&D Center in Chicago, marking a major expansion of the company’s regional operations and long-term commitment to supporting the development of genetic medicines. The new Center will combine research and development with manufacturing capabilities across VectorBuilder’s gene delivery portfolio. Planned as a multi...

VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026

CHICAGO--(BUSINESS WIRE)--VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, will participate in the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, taking place May 11 to 15 in Boston, Massachusetts. As gene and cell therapies move closer to clinical and commercial scale, the industry is placing greater scrutiny on how early vector design decisions influence manufacturability, consistency, and downstream outcomes. These considerations are expec...
Back to Newsroom